Monday, 27 August 2018

Global 3D Printing Market in Healthcare – Analysis and Forecast (2018-2024)


3D-printing Market in Healthcare.png

3D printing technology produces and manufactures customizes medical equipment, medical devices, prosthetics and products. The global 3D printing market in healthcare is growing at significant rate, due to mounting need for implants. Different types contributed to the 3D printing market in healthcare size. The market has witnessed high demand for surgical guides over the last few years due to mounting usage of the digitally focused process for precise surgical preparation.


Socio-ethical concerns related to the usage of 3D-printed products, strict regulatory procedure for the approval of the 3D printed medical devices, high cost associated with the advanced 3D printers, patent issues related to 3D printing and lack of trained professionals are the major challenges for the growth of 3D printing market in healthcare.

Globally, the manufacturing companies trying to enter the 3D printing market in healthcare are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest 3D printing in healthcare market as in the region the demand for organ transplants is increasing. In addition, highly developed healthcare infrastructure, expanding geriatric population, mounting need for implants, technological improvements, conferences and trade, mounting number of patients with dental problems and hearing loss and government & private assets to progress innovative 3D printing technologies & applications are also up surging growth of the North American 3D printing market in healthcare.

Asia-Pacific is observed to witness fastest growth in the market, due to mounting adoption of 3D printing medical devices. In addition, establishment of novel 3D printing research, education and training centers, expanding geriatric population, improving healthcare infrastructure, mounting number of patients with dental problems and hearing loss, large population base and mounting healthcare expenditure are also creating a positive impact on the 3D printing market in healthcare growth in the region.


Key players in the 3D printing market in healthcare are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In June 2018, 3D Systems introduced DMP Flex 100 and DMP Dental 100 3D printers, to provide versatility and material for entrance level metal 3D printing and dental applications.

In addition, in February 2018, EnvisionTEC launched 3D printing orthodontic models to create clear thermoformed aligners. Stratasys Ltd., Renishaw plc, Concept Laser GmbH, EnvisionTEC GmbH, 3T RPD Ltd, Materialise NV, 3D Systems Corporation, Arcam AB, Prodways Group and EOS GmbH Electro Optical Systems are the key players offering 3D printing in healthcare.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+

Friday, 24 August 2018

Global Biosurgery Market – Trends, Demands, Size, Share, Growth, Application, Analysis and Forecast (2018-2024)

Biosurgery Market_1.jpg
Biosurgery is the combination of techniques and surgical techniques to decrease post and intra-operative complications. The global biosurgery market is growing at significant rate, due to expanding geriatric population and mounting number of surgeries. Different product and services contributed to the biosurgery market size. The market has witnessed high demand for bone-graft substitutes in the coming years due to mounting usage of bone-graft substitutes in various types of orthopedic surgeries as they decrease surgical time.


High cost of biosurgery products & escalating cost of surgical procedures, lack of skilled professionals for effectual use of biosurgery products, and strict regulatory framework are the major challenges for the growth of biosurgery market.

Globally, the manufacturing companies trying to enter the biosurgery market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest biosurgery market as in the region the geriatric population is increasing. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.

Mounting number of trauma injuries, mounting number of surgical procedures, mounting healthcare expenditure, mounting occurrence of chronic diseases and lifestyle associated diseases and advance technological amendment are also up surging growth of the North American biosurgery market. For instance, according to Centers for Disease Control and Prevention in 2012, approximately 117 million people in the U.S. had one or the more chronic conditions.


Asia-Pacific is observed to witness fastest growth in the market, due to expanding geriatric population and refining healthcare infrastructure. In addition, mounting healthcare expenditure, mounting occurrence of chronic diseases and lifestyle associated diseases, escalating number of surgical procedures, and mounting demand for effectual blood loss management are also creating a positive impact on the biosurgery market growth in the region.

Key players in the biosurgery market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In April 2018, Medtronic PLC received FDA approval of Infuse Bone Graft. It is used with spine implants composed of polyetheretherketone in oblique lateral interbody fusion and anterior lumbar interbody fusion procedures. Baxter International, Inc., Medtronic, PLC., Hemostasis, LLC, B.Braun Melsungen AG, Cohera Medical Inc., C.R. Bard, Sanofi, Johnson & Johnson, Getinge Group and Integra Lifesciences Holdings Corporation are the key players offering biosurgery.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+

Global Transradial Access Devices Market – Analysis and Forecast (2018-2024)

Transradial Access Devices Market
Transradial access devices are utilized in the endovascular or catheterization procedure to execute the analysis and treatment of any kind of the arterial disease. Its kit includes various minor components such as catheters, accessories, sheaths and sheath introducers and guidewires. The global transradial access devices market is growing at significant rate, due to mounting occurrence of lifestyle associated diseases and technological improvements. Different products contributed to the transradial access devices market size. The market has witnessed high demand for catheters over the last few years due to budding amount of interventional and angiography procedures.


The lack of skilled professionals, high costs involved in the placement and maintenance of vascular access devices, risks associated with radial access devices, and product recalls and failures are the major challenges for the growth of transradial access devices market.

Globally, the manufacturing companies trying to enter the transradial access devices market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North American is the largest transradial access devices market as in the region the occurrence of cardiovascular disease is increasing. For instance, according to Centers of Disease Control and Prevention (CDC), in the U.S. approximately 610,000 people die every year due to heart disease. Moreover, according to CDC, approximately 370,000 people die annually due to coronary heart disease in the U.S. It is the most common type of heart disease in the U.S.

Mounting occurrence of cancer, upsurge in clinical trials and research for vascular access devices, expanding geriatric population, improved healthcare infrastructure, and increasing number of conferences, and workshops are also up surging growth of the North American transradial access devices market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.


Key players in the transradial access devices market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2018, Medtronic Plc announced advanced SynergyTLIF workflow, an integrated fully navigated procedure with less surgical procedures for lumbar spine surgery. Moreover, in February 2017, Medtronic Plc received FDA and CE clearance for DxTerity Diagnostic Angiography Catheter line and transradial-specific products such as TRAcelet compression device, DxTerity TRA, and InTRAkit access kit.

Becton, Dickinson and Company, Merit Medical Systems, Terumo Corporation, Teleflex Incorporated, Boston Scientific Corporation, Ameco Medical, Smiths Medical, Nipro Medical Corporation, Medtronic PLC, Angiodynamics, Inc, Edward Lifesciences Corporation, and Oscor Inc. are the key players offering transradial access devices.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+

Global Diagnostic Imaging Market - Popular Trends & Technological Advancements to Watch Out for Near Future 2024


Diagnostic Imaging_2.jpg




Diagnostic imaging is a procedure to generate image of internal and external body parts for clinical purpose. It has its application in several medical fields such as neurology, cardiology, orthopedics, and oncology. The global diagnostic imaging market is growing at significant rate, due to mounting occurrence chronic diseases and boosting number of diagnostic centers. Different product contributed to the diagnostic imaging market size. The market has witnessed high demand for x-ray imaging systems in the coming years due to mounting demand for mobile x-ray system, expanding geriatric population and mounting occurrence of diseases and injuries.


Mounting implementation of refurbished diagnostic imaging systems, lack of skilled professionals, elevated price of diagnostic imaging systems, disapproving healthcare reforms in the U.S., and technological restrictions associated with standalone systems are the major challenges for the growth of diagnostic imaging market.

Globally, the manufacturing companies trying to enter the diagnostic imaging market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest diagnostic imaging market as in the region the occurrence of chronic diseases is increasing. For instance, according to GLOBOCAN in the U.S. approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012. Expanding geriatric population, technological developments in diagnostic imaging modalities and mounting inclination for minimally invasive treatment are also up surging growth of the North American diagnostic imaging market.


Asia-Pacific is observed to witness fastest growth in the market, due to mounting occurrence of chronic diseases. In addition, expanding geriatric population, mounting medical tourism, improving healthcare infrastructure and mounting healthcare expenditure are also creating a positive impact on the diagnostic imaging market growth in the region.

Key players in the diagnostic imaging market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In February 2016, Carestream introduced digital X-ray technology that delivers rapid access to diagnostic images. Carestream’s Cone Beam CT System helps physicians to assess players’ injuries during the matches. It is specially designed for orthopaedic imaging. GE Healthcare, Hitachi Ltd., Siemens AG, Samsung Medison, Carestream Health, Koninklijke Philips N.V., Esaote S.P.A, Shimadzu Corporation, Toshiba Corporation, and Fujifilm Holdings Corporation are the key players offering diagnostic imaging.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+

Global Hernia Repair Market - Popular Trends & Technological Advancements to Watch Out for Near Future 2024


Hernia Repair Market_1.png

Hernia is a medical condition where an organ or fatty tissue protrudes out via a weak point. Hernia repair is a surgical procedure performed for the management of a hernia. Laparoscopic repair surgery and open tension-free repair surgery are the major methods for hernia repair. The global hernia repair market is growing at significant rate, due to mounting occurrence hernia, expanding geriatric population and technological improvement. Different products contributed to the hernia repair market size. The market has witnessed high demand for mesh in the coming years due to higher cost of meshes contrasted to mesh fixators.


Elevated price of mesh repair, lack of skilled professionals, accessibility of less massive approaches and lengthy waiting period in developed countries are the major challenges for the growth of hernia repair market. In addition, complications related to hernia repair are also hindering the growth of the hernia repair market. For instance, according to FDA, pain, infection, hernia recurrence, adhesion, obstruction, bleeding, and a hole in neighboring tissues or organs are the complications related to hernia repair.

Globally, the manufacturing companies trying to enter the hernia repair market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest hernia repair market as in the region the acceptance of hernia repair is increasing. In addition, expanding geriatric population, presence of large pool of hernia patients, mounting healthcare expenditure, technological improvement, and efficient and favorable healthcare system are also up surging growth of the North American hernia repair market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.


Asia-Pacific is observed to witness fastest growth in the market, due to expanding geriatric population. In addition, mounting medical tourism, improving healthcare infrastructure and mounting healthcare expenditure are also creating a positive impact on the hernia repair market growth in the region.

Key players in the hernia repair market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2017, Integra LifeSciences Holdings Corporation launched SurgiMend MP a tissue-building solutions for complex abdominal hernia repair.

In addition, in April 2017, Becton, Dickinson and Company acquired Bard, to provide innovative healthcare solutions and to improve its product portfolio. B. Braun Melsungen AG, Becton, Dickinson and Company, Getinge AB, Johnson & Johnson, Cook Group Inc., Medtronic PLC., Integra Lifesciences Holdings Corporation, W. L. Gore & Associates, Via Surgical and Herniamesh are the key players offering repair products.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+

Thursday, 23 August 2018

Global Cerebrospinal Fluid Management Market - Popular Trends & Technological Advancements to Watch Out for Near Future 2024


Cerebrospinal Fluid Management.jpg

Cerebrospinal fluid (CSF) management is clear and colorless body fluid found in the brain and spine which acts as a support for the brain, providing basic mechanical and immunological protection to the brain inside the skull. The global cerebrospinal fluid management market is growing at significant rate, due to mounting occurrence hydrocephalus and expanding geriatric population. Different product contributed to the cerebrospinal fluid management market size. The market has witnessed high demand for shunts in the coming years due to mounting number of shunting procedures and expanding geriatric population.

  
Lack of skilled professionals and high cost of shunts are the major challenges for the growth of cerebrospinal fluid management market. Complications associated with CSF shunts are hindering the growth of the cerebrospinal fluid management market. For instance, shunt malfunction, shunt infection, under drainage, subdural hematoma, seizures, multiloculated hydrocephalus and over drainage are the complications associated with the CSF shunts.

Globally, the manufacturing companies trying to enter the cerebrospinal fluid management market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest cerebrospinal fluid management market as in the region the occurrence of hydrocephalus increasing. Mounting funding for hydrocephalus research, mounting occurrence of neurological disorders, expanding geriatric population, mounting demand for minimally invasive procedure, rapid technological advancement and the initiate of organizations are also up surging growth of the North American cerebrospinal fluid management market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.


Asia-Pacific is observed to witness fastest growth in the market, due to mounting occurrence of hydrocephalus and increasing awareness about neurological diseases. In addition, improving healthcare infrastructure, mounting medical tourism, mounting demand for minimally invasive procedure, mounting occurrence of stroke disease, expanding geriatric population and mounting healthcare expenditure are also creating a positive impact on the cerebrospinal fluid management market growth in the region.

Key players in the cerebrospinal fluid management market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2016, Medtronic PLC, received FDA clearance for StrataMR valves and shunts, for treatment of patients with hydrocephalus and cerebrospinal fluid disorders.

In addition, in April 2017, Medtronic PLC, voluntary recalls all unused StrataMR valves and shunts. Medtronic PLC, Spiegelberg GmbH & Co. Kg, Deltasurgical, Integra Lifesciences Holdings Corporation, Natus Medical Incorporated, G.SURGIWEAR LTD, B. Braun Melsungen, Dispomedica GmbH, SOPHYSA, Moller Medical GmbH, and Wellong Instruments Co., Ltd are the key players offering cerebrospinal fluid management.

About VynZ Research :

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+

Global Fertility Test Market - Popular Trends & Technological Advancements to Watch Out for Near Future 2024

Fertility Test.jpg
Fertility test is a process by which fertility is accessed. The global fertility test market is growing at significant ate, due to Escalating first-time pregnancy age, introduction of innovative fertility monitors with high-level precision. Different products contributed to the fertility test market size. The market has witnessed high demand for ovulation predictor kits in the coming years due minimal charge as contrasted to fertility monitors, and less price and high efficiency.


High price of fertility testing monitors, untested precision of urine-based ovulation monitors and reduced precision of ovulation prediction kits are the major challenges for the growth of fertility test market.

Globally, the manufacturing companies trying to enter the fertility test market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest fertility test market as in the region the usage of fertility monitoring device for contraception is increasing.

Escalating first-time pregnancy age, mounting awareness about the benefits of ovulation monitors through social media, e-commerce sites and marketing campaigns, and mounting occurrence of polycystic ovary syndrome are also up surging growth of the North American fertility test market. For instance, according to the Centre for Disease Control and Prevention (CDC) report on National Vital Statistics Report 2015, in the U.S., the mean age of mother at first birth was 25.8 years in 2012, and it has increased to 26 years in 2013.


Asia-Pacific is observed to witness fastest growth in the market, due to mounting occurrence of lifestyle disorders. In addition, mounting funding for the improvement of fertility and ovulation monitors and mounting number of manufacturers and suppliers of fertility testing are also creating a positive impact on the fertility test market growth in the region.

Key players in the fertility test market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In December 2016, Prestige Brands Holdings, Inc. has entered into a definitive agreement to acquire C.B. Fleet Company, to enhance its product portfolio in feminine care and other over-the-counter healthcare products.

In July 2016, Ava launched Ava Bracelet, a fertility tracking sensor bracelet, to detect the fertility days during a women’s cycle. Advacare Pharma, Biozhena, Fertility Focus, Prestige Brands Holdings, AVA, SPD Swiss Precision Diagnostics, Fairhaven Health, Taidoc, Babystart, Hilin Life Products, Church & Dwight, Sensiia and Geratherm Medical are the key players offering fertility test.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+

Wednesday, 22 August 2018

Global Healthcare/Medical Simulation Market – Analysis and Forecast (2018-2024)


Medical Simulation Market.jpg

Healthcare simulation is a method of imitating a real-life medical state to reveal and educate healthcare professionals. It is guiding healthcare professionals through usage of innovative technology. The global healthcare/medical simulation market is growing at significant rate, due to advantages of simulation over conventional learning, mounting need for minimally invasive treatments. Different product and services contributed to the healthcare/medical simulation market size. The market has witnessed high demand for anatomical models over the last few years due to mounting primary care services, and scarcity of healthcare professionals.


Globally, the manufacturing companies trying to enter the healthcare/medical simulation market are required to maintain stringent regulatory standards. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest medical simulation market as in the region the number of healthcare professionals is increasing. Easiness of availability to technologies, elevated acceptance of simulation by medical universities and training centers, improved healthcare infrastructure, and entrenched distribution channels are also up surging growth of the North American healthcare/medical simulation market.

Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base. In addition, mounting awareness on simulation learning, refining healthcare infrastructure, budding focus on the global medical simulation players, mounting healthcare expenditure and mounting emphasis on patient safety are also creating a positive impact on the healthcare/medical simulation market growth in the region.


Key players in the healthcare/medical simulation market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2018, 3D Systems launched Simbionix ANGIO Tab Pro endovascular simulator for step-by-step teaching of endovascular interventions. In addition, in June 2017, CAE Healthcare introduced CAE Juno, a recently invented clinical skills manikin for nursing programs, in International Nursing Association for Clinical Simulation and Learning (INACSL) annual conference in Washington.

CAE and Laerdal Medical accounted the major share in the market. CAE, Simulab Corporation, 3D Systems Inc., Mentice AB, Gaumard Scientific Company, Simulaids Inc., Kyoto Kagaku Co., Ltd, Limbs & Things Ltd., Laerdal Medical and Medaphor are the key players offering healthcare/medical simulation.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+

Global Immunoassay Market Research Report – Analysis and Forecast (2018-2024)


Immunoassay market_1.png

Immunoassay is a technique of measurable determination of chemical substance such as specific protein, hormones and drugs, which employs the highly precise binding between the antigen and antibody. The global immunoassay market is growing at significant rate, due to mounting occurrence of chronic and infectious diseases and technological improvement in the instruments. Different product and services contributed to the immunoassay market size. The market has witnessed high demand for kits and reagents over the last few years due to mounting number of immunoassay tests and mounting occurrence of chronic and infectious diseases.


The strict regulatory requirements for the sanction of immunoassay instruments and consumables, employment of excise duty on the sale of medical devices in the U.S. complexities in conducting diagnostic tests and unfavorable compensation scenario are the major challenges for the growth of immunoassay market.Globally, the manufacturing companies trying to enter the immunoassay market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest prefilled syringe market as in the region the prevalence of chronic disease and infectious diseases is increasing. Accessibility of government assets, mounting usage of immunoassays in clinical diagnostics, improved healthcare infrastructure, and the existence of key players are also up surging growth of the North American immunoassay market.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/immunoassay-market

Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base. In addition, mounting occurrence of infectious diseases and chronic diseases and refining healthcare infrastructure are also creating a positive impact on the immunoassay market growth in the region.

Key players in the immunoassay market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In June 2016, Roche launched the cobas e 801 module, a testing immunoassay solution, in order to meet the demand for increased diagnostic testing. Roche, Agilent Technologies, Abbott Laboratories, Thermo Fisher Scientific, Siemens, QIAGEN, Danaher, Ortho Clinical Diagnostics, Sysmex, Bio-Rad Laboratories, BioMérieux, Becton, Dickinson & Company, and Mindray are the key players offering immunoassay.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+



Global Medication Management Market – Analysis and Forecast (2018-2024)


Medication Management Market.jpg

Medication management allows prescribing, administration and supply of medicines to be tracked and validated electronically. The global medication management market is growing at significant rate, due to mounting occurrence of chronic diseases and rapid growth in geriatric population. Different systems and services contributed to the medication management market size. The market has witnessed high demand for computerized physician order entry systems over the last few years due to mounting demand for remote patient monitoring services.


Unwillingness to accept medication management systems, privacy and safety issues and high price of implementation and maintenance are the major challenges for the growth of medication management market.

Globally, the manufacturing companies trying to enter the medication management market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest medication management market as in the region the prevalence of chronic disease is increasing. For instance, according to Centers of Disease Control and Prevention (CDC), in the U.S. approximately 610,000 people die every year due to heart disease. Growing geriatric population, technological innovation and boosting government funding are also up surging growth of the North American medication management market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.


Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base. In addition, expanding geriatric population, mounting occurrence of chronic diseases and refined healthcare infrastructure are also creating a positive impact on the medication management market growth in the region.

Key players in the medication management market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In October 2017, Allscripts Healthcare Solutions, Inc., acquired McKesson Corporation’s hospital and health system IT business, to improve its product portfolio. Allscripts Healthcare Solutions, Inc., Cerner Corporation, Carefusion Corporation, Siemens Healthcare, GE Healthcare, Optum Inc., Quadramed Corporation, Omnicell, Inc. and Meditech are the key players offering medication management.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+

Global Microbial Identification Market Future Outlook : Investment Trends, Growth and Future Market Analysis by 2024


Microbial Identification market_1.jpg

Microbial identification is a method of accurate and conclusive detection of microorganisms, such as viruses, bacteria, and pathogen. It is broadly implemented in healthcare and management such as infection treatments and disease diagnosis. The global microbial identification market is growing at significant rate, due to mounting occurrence infectious diseases and technological improvement. Different product and services contributed to the microbial identification market size. The market has witnessed high demand for instruments in the coming years due to widespread usage of instruments.


Elevated price of automated microbial identification systems and complicated regulatory frameworks are the major challenges for the growth of microbial identification market.
Globally, the manufacturing companies trying to enter the microbial identification market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest microbial identification market as in the region the acceptance of microbial techniques for research is increasing. Mounting occurrence of infectious diseases, safety concerns, budding occurrence of foodborne infections, and technological developments in microbial identification products are also up surging growth of the North American microbial identification market.


Asia-Pacific is observed to witness fastest growth in the market, due to budding need for microbial identification. In addition, mounting occurrence of infectious diseases, improving healthcare infrastructure and mounting healthcare expenditure are also creating a positive impact on the microbial identification market growth in the region.

Key players in the microbial identification market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In March 2018, Danaher Corporation signed an agreement to acquire Integrated DNA Technologies to expand its presence in genomic market. Becton, Dickinson and Company, Biomérieux S.A., Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, Danaher Corporation, VWR Corporation, Merck KGaA, Eurofins Scientific S.E., Charles River Laboratories International, Inc. and Wickham Laboratories Ltd are the key players offering microbial identification.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+












Tuesday, 21 August 2018

Global Nucleic Acid Isolation and Purification Market Future Outlook : Investment Trends, Growth and Future Market Analysis by Regions!


Nucleic Acid Isolation and Purification.jpg

Nucleic acid isolation and purification is molecular biology studies and recombinant DNA techniques. The process of isolation includes mechanical and chemical disruption and enzymatic digestion, whereas the purification involves electrophoresis, extraction, chromatography, affinity separation and centrifugation.  The global nucleic acid isolation and purification market is growing at significant rate, due to mounting public-private finance for life science research. Different product contributed to the nucleic acid isolation and purification market size. The market has witnessed high demand for kits over the last few years due to easiness of usage in applications such as gene cloning, gene sequencing, and molecular diagnostics.


The high cost of automated instruments and low market penetration for automated procedure are the major challenges for the growth of nucleic acid isolation and purification market.
Globally, the manufacturing companies trying to enter the nucleic acid isolation and purification market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest nucleic acid isolation and purification market as in the region the government support is increasing. Major R&D expenditure in biotechnology and pharmaceutical companies, and technological improvements, are also up surging growth of the North American nucleic acid isolation and purification market.


Asia is observed to witness fastest growth in the market, due to promising government investments in the life sciences division. In addition, lesser manufacturing expenses and mounting occurrence of market players in emerging economies are also creating a positive impact on the nucleic acid isolation and purification market growth in the region.

Key players in the nucleic acid isolation and purification market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2017, Thermo Fisher Scientific launched PureLink Expi Endotoxin-Free Maxi Plasmid Purification Kit, to improve its product portfolio of endotoxin-free plasmid DNA isolation products. Thermo Fisher Scientific, F. Hoffman-La Roche, Danaher Corporation, Qiagen N.V., Illumina, Agilent Technologies, Merck KGaA, Promega Corporation, Bio-Rad Laboratories and GE Healthcare are the key players offering nucleic acid isolation and purification.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+







Global Operating Room Management Market Future Outlook : Investment Trends, Growth and Future Market Analysis by Regions!


Operating Room Management_1.jpg

Operating room (OR) management assists improved coordination and consultation between several surgical teams. It emphases on maximum number of tasks that can be completed with minimum required resources and related cost. The global operating room management market is mounting occurrence of chronic diseases technological improvement, and expanding geriatric population. Different components contributed to the operating room management market size. The market has witnessed high demand for software over the last few years due to propelling fitting of ORM software.



The lack of skilled professionals, and high cost of operating room management software and maintenance are the major challenges for the growth of operating room management market.
Globally, the manufacturing companies trying to enter the operating room management market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest operating room management market as in the region the occurrence of chronic disease is increasing. For instance, according to Centers of Disease Control and Prevention (CDC), in the U.S. approximately 610,000 people die every year due to heart disease. Growing geriatric population, escalating emphasis on activities to generate alertness about OR management, great amount of operating room procedure and mounting healthcare expenditure are also up surging growth of the North  American operating room management market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.


Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base. In addition, expanding geriatric population, mounting occurrence of chronic diseases, refining IT infrastructure, and mounting requirement to limit healthcare cost are also creating a positive impact on the operating room management market growth in the region.

Key players in the operating room management market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2017, Becton, Dickinson and Company collaborated with UniteOR, Inc., to supply a combined tracking solution for operating room setting and provide better visibility into surgical tracking management. Becton, Dickinson and Company, STERIS, DXC Technology Company, Cerner Corporation, Allscripts Healthcare Solutions, Omnicell, McKesson Corporation, GE Healthcare, Optum, Nexus AG, Getinge and Surgical Information Systems are the key players offering operating room management.

About VynZ Research :

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+

Global Patient Monitoring Device Market Future Outlook : Investment Trends, Growth and Future Market Analysis by Regions!


Patient Monitoring Device.jpg

Patient monitoring devices are used for detection, continuous monitoring and treatment various body parts such as lungs, heart and brain. These devices are essential for hospitals and other healthcare facilities. The global patient monitoring device market is growing at significant rate, due to mounting occurrence chronic and lifestyle associated diseases and boosting demand of patient monitoring in remote and non-hospital settings. Different product contributed to the patient monitoring device market size.


 Threats related with invasive monitoring devices and strict regulatory requirements for the approval of devices are the major challenges for the growth of patient monitoring device market.
Globally, the manufacturing companies trying to enter the patient monitoring device market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.Geographically, North America is the largest patient monitoring device market as in the region the occurrence of chronic and lifestyle associated diseases is increasing. For instance, according to according to Centers of Disease Control and Prevention (CDC), in the U.S. approximately 610,000 people die every year due to heart disease. Technological advancement in patient monitoring devices, advanced healthcare infrastructure, high healthcare expenditure and expanding geriatric population are also up surging growth of the North American patient monitoring device market.


Asia is observed to witness fastest growth in the patient monitoring device market, due to mounting healthcare expenditure. In addition, mounting occurrence of chronic and lifestyle associated diseases, and budding public health alertness are also creating a positive impact on the patient monitoring device market growth in the region.

Key players in the patient monitoring device market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In April 2018, Masimo received CE marking for Rad-97 pulse CO-oximeter with integrated NomoLine capnography, for continuous oxygenation and ventilation monitoring. Medtronic PLC, Edward Lifesciences, Natus Medical, Masimo, Koninklijke Philips N.V., Nihon Kohden, Hill-Rom Holdings, Drägerwerk AG, Omron and GE Healthcare are the key players offering patient monitoring device.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+




Top trends influencing "Point of Care/Rapid Diagnostic Market" outlook: An in-depth analysis of the global industry expansion


Point of care diagnostic allows diagnoses in the remote setting, home, physician’s office, or in the hospital. The outcomes of diagnosis are rapid, and allow speedy treatment to the patient. The global point of care/rapid diagnostic market is growing at significant rate, due to mounting occurrence of infectious diseases and technological improvements and innovative product launches. Different products contributed to the point of care/rapid diagnostic market size. The market has witnessed high demand for infectious disease testing over the last few years due escalating accessibility and alertness about infectious disease POC testing products.


The product recalls, expanding development period for product launches, limited reimbursements, and strict and time exhausting regulatory policies are the major challenges for the growth of point of care/rapid diagnostic market. In addition, lack of alignment with definitive central lab methods, elevated price of devices, insufficient expertise about the usage of POC devices in professional settings and disinclination towards altering existing diagnostic practices are some of the factors hindering the growth of the market.

Globally, the manufacturing companies trying to enter the point of care/rapid diagnostic market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Globally, the manufacturing companies trying to enter the point of care/rapid diagnostic market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.


Geographically, North America is the largest point of care/rapid diagnostic market as in the region the occurrence of lifestyle associated diseases is increasing. Mounting number of product approvals and expanding government schemes are also up surging growth of the North American point of care/rapid diagnostic market.

Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base. In addition, mounting occurrence of lifestyle associated diseases, budding government initiatives, and escalating occurrence of infectious disease are also creating a positive impact on the point of care/rapid diagnostic market growth in the region.

Key players in the point of care/rapid diagnostic market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In June 2018, Abbott received FDA clearance for the Afinion HbA1c diagnostic assay for identifying patients at risk of diabetes and diagnosing diabetes.

Abbott Laboratories, Danaher Corporation, Accubiotech, Johnson & Johnson, Becton, Dickinson, and Company, EKF Diagnostics, Nova Biomedical, Quidel, Roche Diagnostics, Chembio Diagnostics, PTS Diagnostics and Instrumentation Laboratory are the key players offering point of care/rapid diagnostic.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.
Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | TwitterFacebook | Google+





Monday, 20 August 2018

Global Sterilization Services Market Future Outlook : Investment Trends, Growth and Future Market Analysis by Regions!

sterilization services.jpg
Sterilization is the method of abolishing all microorganisms and their pathogenic products. The global sterilization services market is growing at significant rate, due to mounting emphasis on outsourcing of sterilization processes among medical device manufacturers and escalating occurrence of hospital-acquired infections. Different types of sterilization services contributed to the sterilization services market size. The market is expected to witness high demand for contract sterilization services due to budding inclinations for contract sterilization by medical device.


The injurious causes of ethylene oxide and sterilization of innovative medical instruments are the major challenges for the growth of sterilization services market.

Globally, the manufacturing companies trying to enter the sterilization services market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest sterilization services market as in the region the occurrence of hospital acquired infections is increasing. Mounting outsourcing of sterilization services by hospitals and medical devices companies, mounting guidelines for the usage of sterilized medical devices, and escalating number of surgeries executed in the U.S., are also up surging growth of the North American sterilization services market.


Asia-Pacific is observed to witness fastest growth in the market, due to refined healthcare infrastructure. In addition, expending medical tourism, mounting occurrence of nosocomial infections, and expanding medical device and pharmaceutical industry are also creating a positive impact on the sterilization services market growth in the region.

Key players in the sterilization services market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. For instance, in April 2018 Cantel Medical Corporation received U.S. Food and Drug Administration 510 (k) clearance for ADVANTAGE PLUS Pass-Thru automated endoscope reprocessor in order to confirm the quality in infection inhibition by decreasing the threat of human error. Steris, Johnson & Johnson, E-Beam Services, Life Science Outsourcing, Cantel Medical Corporation, Beta-Gamma-Service, Medistri, Sterigenics International, Cretex Companies, Noxilizer and Stryker are the key players offering sterilization services.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA
165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook

Global Vascular Patches Market – Analysis and Forecast (2018-2024)

vascular patches market.jpg
Patches are covering applied to protect a wound or sore. Vascular patches are elastic material ensures minimal suture hole, bleeding and compliance. The global vascular patches market is growing at significant rate, due to mounting occurrence vascular diseases and mounting acceptance of biological patches. Different materials contributed to the vascular patches market size. The market has witnessed high demand for biologic patches in the coming years due to benefits of biologic patches such as easiness of usage, and decreased rate of infection.


Demand for trained professionals, reducing number of carotid endarterectomy surgeries and product failures and recalls are the major challenges for the growth of vascular patches market.

Globally, the high level of capital requirement for companies trying to enter the vascular patches market poses a major barrier for the entry of new players. Moreover, the stringent regulatory requirements are also posing barrier for the new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest vascular patches market as in the region the geriatric population is increasing. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050. Mounting occurrence of vascular diseases, and mounting acceptance of biological patches are also up surging growth of the North American vascular patches market.


Asia-Pacific is observed to witness fastest growth in the market, due to large pool of patients. In addition, expanding geriatric population, mounting alertness regarding advanced vascular products, refining healthcare infrastructure and mounting healthcare expenditure are also creating a positive impact on the vascular patches market growth in the region.

Key players in the vascular patches market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In November 2016, LeMaitre Vascular, Inc. acquired Restore Flow Allografts, LLC, to improve its biologic product range. In January 2017, Terumo Corporation acquired certain assets of Abbott and St Jude Medical of vascular closure business, to support efficient and safe intervention procedure.

LeMaitre Vascular, C. R. Bard, Terumo Corporation, Baxter International, Admedus, Edwards Lifesciences, Maquet, Edwards Lifesciences, W. L. Gore & Associates, Labcor, B.Braun, and Cryolife are the key players offering vascular patches.

About VynZ Research :

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA
165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook